Why is Mankind Pharma falling/rising?

As of 24-Jul, Mankind Pharma Ltd's stock price is currently at Rs 2,590.00, reflecting a decrease of Rs 39.4 or 1.5%. The stock has been underperforming recently, having fallen consecutively for the last two days, resulting in a total decline of 3.02% during this period. Today's trading saw the stock reach an intraday low of Rs 2,550.4, and it has underperformed its sector by 1.85%. Despite this decline, the stock has shown a strong performance over the past year, with a return of 22.73%, significantly outpacing the market's return of 0.99%. The company benefits from high management efficiency, a low Debt to EBITDA ratio, and healthy long-term growth, which could support its price in the future.
In the broader market context, Mankind Pharma's short-term performance has been weaker compared to the benchmark Sensex, which has only seen a minor decline of 0.09% over the past week. While the stock has experienced a downturn recently, it has shown resilience with a 12.04% increase over the past month, indicating potential for recovery. The rising investor participation, as evidenced by an 18.89% increase in delivery volume, suggests that there is still interest in the stock despite its current price decline. Overall, while Mankind Pharma is facing short-term challenges, its strong fundamentals and historical performance may provide a foundation for future growth.